CH625345A5 - - Google Patents
Download PDFInfo
- Publication number
- CH625345A5 CH625345A5 CH684276A CH684276A CH625345A5 CH 625345 A5 CH625345 A5 CH 625345A5 CH 684276 A CH684276 A CH 684276A CH 684276 A CH684276 A CH 684276A CH 625345 A5 CH625345 A5 CH 625345A5
- Authority
- CH
- Switzerland
- Prior art keywords
- antibodies
- antigens
- aluminum hydroxide
- serum
- antigen
- Prior art date
Links
- 238000000034 method Methods 0.000 claims description 32
- 239000000427 antigen Substances 0.000 claims description 25
- 102000036639 antigens Human genes 0.000 claims description 25
- 108091007433 antigens Proteins 0.000 claims description 25
- 229940024546 aluminum hydroxide gel Drugs 0.000 claims description 10
- SMYKVLBUSSNXMV-UHFFFAOYSA-K aluminum;trihydroxide;hydrate Chemical compound O.[OH-].[OH-].[OH-].[Al+3] SMYKVLBUSSNXMV-UHFFFAOYSA-K 0.000 claims description 10
- 210000001124 body fluid Anatomy 0.000 claims description 10
- 239000010839 body fluid Substances 0.000 claims description 10
- 239000003463 adsorbent Substances 0.000 claims description 8
- 238000001514 detection method Methods 0.000 claims description 4
- 210000002966 serum Anatomy 0.000 description 22
- 239000000203 mixture Substances 0.000 description 18
- 239000000872 buffer Substances 0.000 description 14
- 239000007788 liquid Substances 0.000 description 14
- 239000013566 allergen Substances 0.000 description 13
- 230000000694 effects Effects 0.000 description 10
- 239000000284 extract Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 229940074608 allergen extract Drugs 0.000 description 9
- 238000010790 dilution Methods 0.000 description 9
- 239000012895 dilution Substances 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 208000001840 Dandruff Diseases 0.000 description 7
- 230000000172 allergic effect Effects 0.000 description 7
- 208000010668 atopic eczema Diseases 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- 238000005119 centrifugation Methods 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 206010020751 Hypersensitivity Diseases 0.000 description 5
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 5
- 229940024545 aluminum hydroxide Drugs 0.000 description 5
- 230000008878 coupling Effects 0.000 description 5
- 238000010168 coupling process Methods 0.000 description 5
- 238000005859 coupling reaction Methods 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 229960004784 allergens Drugs 0.000 description 4
- 229940046528 grass pollen Drugs 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 241000746983 Phleum pratense Species 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 150000002367 halogens Chemical class 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- WSWCOQWTEOXDQX-MQQKCMAXSA-M (E,E)-sorbate Chemical compound C\C=C\C=C\C([O-])=O WSWCOQWTEOXDQX-MQQKCMAXSA-M 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- HDVDLQFPDLTOSI-UHFFFAOYSA-L O[AlH]O Chemical compound O[AlH]O HDVDLQFPDLTOSI-UHFFFAOYSA-L 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- YBCVMFKXIKNREZ-UHFFFAOYSA-N acoh acetic acid Chemical compound CC(O)=O.CC(O)=O YBCVMFKXIKNREZ-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 235000001513 akia Nutrition 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- -1 as mentioned Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000012886 linear function Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 229940075554 sorbate Drugs 0.000 description 1
- 239000002594 sorbent Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229920003176 water-insoluble polymer Polymers 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Inorganic Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK259875AA DK140815B (da) | 1975-06-10 | 1975-06-10 | Fremgangsmåde til påvisning eller bestemmelse af antistoffer i legemsvæsker ved hjælp af kendte antigener eller til bestemmelse af antigener ved hjælp af kendte antistoffer fra legemsvæsker samt et middel til anvendelse ved udøvelse af fremgangsmåden. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH625345A5 true CH625345A5 (enExample) | 1981-09-15 |
Family
ID=8113555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH684276A CH625345A5 (enExample) | 1975-06-10 | 1976-06-01 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4127385A (enExample) |
| JP (1) | JPS51151323A (enExample) |
| AU (1) | AU505801B2 (enExample) |
| BE (1) | BE842821A (enExample) |
| CA (1) | CA1073352A (enExample) |
| CH (1) | CH625345A5 (enExample) |
| DE (1) | DE2624814C2 (enExample) |
| DK (1) | DK140815B (enExample) |
| FI (1) | FI60319C (enExample) |
| FR (1) | FR2314499A1 (enExample) |
| GB (1) | GB1503409A (enExample) |
| LU (1) | LU75124A1 (enExample) |
| NL (1) | NL7606248A (enExample) |
| NO (1) | NO147048C (enExample) |
| SE (1) | SE427218B (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991002980A1 (en) * | 1989-08-24 | 1991-03-07 | Ramsey Foundation | Method and apparatus for the measurement of organic antigens |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1549069A (en) * | 1976-12-10 | 1979-08-01 | Erba Farmitalia | Enzyme linked immunoassay |
| JPS5917388B2 (ja) * | 1979-02-22 | 1984-04-20 | 富士レビオ株式会社 | 間接凝集反応用吸収剤 |
| JPS56143955A (en) * | 1980-04-10 | 1981-11-10 | Fujirebio Inc | Method for diagnosis of initial infection of syphilis |
| WO1983000505A1 (en) * | 1981-07-31 | 1983-02-17 | Bucher, Doris, J. | Assay for viruses |
| US4551431A (en) * | 1983-04-21 | 1985-11-05 | Phillips Petroleum Company | The use of gallium and indium salts for the immobilization of proteins |
| FR2832507B1 (fr) * | 2001-11-20 | 2004-02-20 | Stago Diagnostica | Methode de detection d'analyte(s) a l'aide de particules magnetiques colloidales |
| US7867715B2 (en) * | 2003-08-05 | 2011-01-11 | Alk-Abello A/S | Method of evaluating the immunological activity of a vaccine |
| MXPA06001382A (es) * | 2003-08-05 | 2006-08-25 | Alk Abello As | Evaluacion de vacunas con adyuvante. |
| GB0607462D0 (en) * | 2006-04-13 | 2006-05-24 | Avecia Ltd | Assay |
| EP2344188B1 (en) * | 2008-10-02 | 2017-02-15 | Pharmathene Inc. | Anthrax vaccine formulation and uses thereof |
| US20100183675A1 (en) * | 2009-01-22 | 2010-07-22 | Allan Watkinson | Stable vaccine compositions and methods of use |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1604135A (enExample) * | 1967-09-26 | 1971-07-12 | ||
| JPS4849919A (enExample) * | 1971-10-23 | 1973-07-14 | ||
| US3867517A (en) * | 1971-12-21 | 1975-02-18 | Abbott Lab | Direct radioimmunoassay for antigens and their antibodies |
| US3776698A (en) * | 1972-01-24 | 1973-12-04 | Nuclear Med Lab | Test for thyroid hormone |
| NL7316346A (enExample) * | 1972-12-11 | 1974-06-13 |
-
1975
- 1975-06-10 DK DK259875AA patent/DK140815B/da not_active IP Right Cessation
-
1976
- 1976-05-27 US US05/690,445 patent/US4127385A/en not_active Expired - Lifetime
- 1976-05-28 SE SE7606082A patent/SE427218B/xx not_active IP Right Cessation
- 1976-06-01 CH CH684276A patent/CH625345A5/de not_active IP Right Cessation
- 1976-06-02 DE DE2624814A patent/DE2624814C2/de not_active Expired
- 1976-06-04 FR FR7617016A patent/FR2314499A1/fr active Granted
- 1976-06-04 GB GB23206/76A patent/GB1503409A/en not_active Expired
- 1976-06-07 CA CA254,269A patent/CA1073352A/en not_active Expired
- 1976-06-09 NO NO761962A patent/NO147048C/no unknown
- 1976-06-09 FI FI761640A patent/FI60319C/fi not_active IP Right Cessation
- 1976-06-09 NL NL7606248A patent/NL7606248A/xx not_active Application Discontinuation
- 1976-06-09 AU AU14753/76A patent/AU505801B2/en not_active Expired
- 1976-06-09 LU LU75124A patent/LU75124A1/xx unknown
- 1976-06-10 JP JP51068175A patent/JPS51151323A/ja active Pending
- 1976-06-10 BE BE167819A patent/BE842821A/xx not_active IP Right Cessation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991002980A1 (en) * | 1989-08-24 | 1991-03-07 | Ramsey Foundation | Method and apparatus for the measurement of organic antigens |
Also Published As
| Publication number | Publication date |
|---|---|
| DE2624814A1 (de) | 1976-12-23 |
| AU505801B2 (en) | 1979-12-06 |
| DK259875A (enExample) | 1976-12-11 |
| DE2624814C2 (de) | 1985-02-21 |
| FR2314499A1 (fr) | 1977-01-07 |
| FI60319C (fi) | 1981-12-10 |
| FI761640A7 (enExample) | 1976-12-11 |
| US4127385A (en) | 1978-11-28 |
| BE842821A (fr) | 1976-10-01 |
| DK140815C (enExample) | 1980-04-08 |
| SE7606082L (sv) | 1976-12-11 |
| GB1503409A (en) | 1978-03-08 |
| NO147048B (no) | 1982-10-11 |
| NL7606248A (nl) | 1976-12-14 |
| DK140815B (da) | 1979-11-19 |
| NO761962L (enExample) | 1976-12-13 |
| JPS51151323A (en) | 1976-12-25 |
| FI60319B (fi) | 1981-08-31 |
| AU1475376A (en) | 1977-12-15 |
| SE427218B (sv) | 1983-03-14 |
| NO147048C (no) | 1983-01-19 |
| FR2314499B1 (enExample) | 1982-08-13 |
| CA1073352A (en) | 1980-03-11 |
| LU75124A1 (enExample) | 1977-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3650513T2 (de) | Verzögerter immunologischer Test in fester Phase | |
| DE3590392C2 (enExample) | ||
| DE69112610T2 (de) | Sammlung von analyten aus der mundhöhle für immunoassays. | |
| DE69218471T2 (de) | Verfahren zur Herstellung von biologisch aktiven Reagentien aus Succinimid enthaltenden Polymeren, analytisches Element und Verwendungsmethoden | |
| DE1598945A1 (de) | Verfahren zur Bestimmung von Proteinen und Polypeptiden | |
| DE3872500T2 (de) | Verwendung eines mit biotin verknuepften immobilisierten rezeptors in einer testvorrichtung, einem testsatz und einer methode zur bestimmung eines liganden. | |
| DE3882058T2 (de) | Immunoreaktives Reagens, Verfahren zu seiner Herstellung und seine Verwendung zur Bestimmung einer immunoreaktiven Spezies. | |
| DE2560288C2 (de) | Probenhalter zur fluorometrischen Bestimmung von Substanzproben | |
| CH625345A5 (enExample) | ||
| CH630465A5 (de) | Verfahren zum nachweis oder zur bestimmung eines antikoerper/antigen-komplexes in einer fluidprobe. | |
| DE2653032A1 (de) | Radioimmun-nachweisverfahren fuer ein schilddruesenhormon und dafuer geeignetes reagens | |
| DD202178A5 (de) | Verfahren und reagens zur untersuchung von antigen-antikoerper-reaktionen | |
| DE2608667A1 (de) | Diagnostisches feststoffreagens und verfahren zu dessen herstellung | |
| DE2737491A1 (de) | Verfahren zur bestimmung eines immunologisch aktiven materials und system zu seiner durchfuehrung | |
| CH626999A5 (en) | Process for the preparation of a stable erythrocyte preparation | |
| EP0001223A2 (de) | Mit einer Polyhydroxyverbindung beschichteten Latex, Verfahren zur Herstellung dieses Latex, immunologisches Reagenz enthaltend diesen Latex, Verfahren zur Herstellung dieses Reagenzes, Verwendung dieses Reagenzes, Bestimmungsverfahren unter Verwendung dieses Reagenzes und Reagenziengarnitur enthaltend dieses Reagenz. | |
| DE2322562A1 (de) | Verfahren zur bestimmung eines oder mehrerer antigene in einer probe | |
| DE2604844C3 (de) | Verfahren zum Nachweis von Hepatitis B-Oberflächenantigen in menschlichem Blut | |
| DE2419884A1 (de) | Verfahren und vorrichtung zur bestimmung von trijodthyronin | |
| DE2523207C2 (de) | Verfahren zur Feststellung der Anwesenheit von Antikörpern | |
| EP0292809B1 (de) | Verfahren zur Bestimmung von Proteinen und Mittel dazu | |
| CH645726A5 (de) | Praeparat zur bestimmung von menschlichem immunoglobulin g, verfahren zu seiner herstellung und seine verwendung. | |
| DE2806860C3 (de) | Verfahren zur Bestimmung der Konzentration der freien Fraktion eines Hormons in einer biologischen Flüssigkeit | |
| DE3338759C1 (de) | Verfahren zum stabilen Binden von proteinischen Antigenen oder Allergenen an feste Traeger | |
| DE2533701A1 (de) | Immunologische diagnoseprodukte |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |